-
Recent Posts
- Good News for China Small-Caps
- An Untapped Opportunity in the Energy Sector
- New Reports on CBLY, FSPI from RedChip Research
- 12 out of 13 Technical Indicators Give Buy Signal on XBOR
- Gold Rally Creates Profit Opportunity for Investors
- Online Ad Spending to Surpass Print in 2012
- One of Healthcare’s Top Trends Expected to Continue
- China’s New Growth Driver and How to Play It
- Asure Gaining Momentum with its Workplace Software Solutions
- Asure Software Engages RedChip to Lead Public and Investor Relations Efforts
- Regulators Take Step Toward Restoring Confidence in China Stocks
- How to Invest in the New U.S. Oil Boom
- Breath-Based Technology Platform Could Revolutionize Disease Diagnosis
- Andover Ventures: A Mining Stock with a Major Near-Term Catalyst
- Longwei Petroleum On Track for a Strong 2012
- 2012 Looks Bright for Energy Efficiency Company Blue Earth
- China Small-Caps That Weathered the Storm Are Opportunities in 2012
- ChromaDex is Positioned for Growth in 2012 and Beyond
Tag Archives: Tod Woolf
RXi Pharmaceuticals presents new research on self-delivering rxRNAs
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi) — a process that can control which genes are expressed within a… Read more